BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 24402230)

  • 1. MicroRNA-195-5p is a potential diagnostic and therapeutic target for breast cancer.
    Luo Q; Wei C; Li X; Li J; Chen L; Huang Y; Song H; Li D; Fang L
    Oncol Rep; 2014 Mar; 31(3):1096-102. PubMed ID: 24402230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
    Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L
    Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Non-coding RNA LINC00473 Promotes Breast Cancer Progression
    Zhang C; Yang T
    Protein Pept Lett; 2023; 30(1):72-84. PubMed ID: 36305147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
    Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
    Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour-suppressive microRNA-424-5p directly targets CCNE1 as potential prognostic markers in epithelial ovarian cancer.
    Liu J; Gu Z; Tang Y; Hao J; Zhang C; Yang X
    Cell Cycle; 2018; 17(3):309-318. PubMed ID: 29228869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA LINC00662 promotes proliferation and migration of breast cancer cells via regulating the miR-497-5p/EglN2 axis.
    Cheng L; Xing Z; Zhang P; Xu W
    Acta Biochim Pol; 2020 Jun; 67(2):229-237. PubMed ID: 32558530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression.
    Yang R; Xing L; Zheng X; Sun Y; Wang X; Chen J
    Mol Cancer; 2019 Jan; 18(1):4. PubMed ID: 30621700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-suppressive function of miR-139-5p in esophageal squamous cell carcinoma.
    Liu R; Yang M; Meng Y; Liao J; Sheng J; Pu Y; Yin L; Kim SJ
    PLoS One; 2013; 8(10):e77068. PubMed ID: 24204738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA LINC01234 silencing exerts an anti-oncogenic effect in esophageal cancer cells through microRNA-193a-5p-mediated CCNE1 downregulation.
    Ma J; Han LN; Song JR; Bai XM; Wang JZ; Meng LF; Li J; Zhou W; Feng Y; Feng WR; Ma JJ; Hao JT; Shen ZQ
    Cell Oncol (Dordr); 2020 Jun; 43(3):377-394. PubMed ID: 32130660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells.
    Zhao Y; Li Y; Lou G; Zhao L; Xu Z; Zhang Y; He F
    PLoS One; 2012; 7(6):e39102. PubMed ID: 22723937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-126-5p Inhibits the Migration of Breast Cancer Cells by Directly Targeting CNOT7.
    Miao Y; Lu J; Fan B; Sun L
    Technol Cancer Res Treat; 2020; 19():1533033820977545. PubMed ID: 33256566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiRNA-497 regulates cell growth and invasion by targeting cyclin E1 in breast cancer.
    Luo Q; Li X; Gao Y; Long Y; Chen L; Huang Y; Fang L
    Cancer Cell Int; 2013 Oct; 13(1):95. PubMed ID: 24112607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-107 induces cell cycle arrests by directly targeting cyclin E1 in ovarian cancer.
    Tang Z; Fang Y; Du R
    Biochem Biophys Res Commun; 2019 Apr; 512(2):331-337. PubMed ID: 30885433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 15. MicroRNA-7 arrests cell cycle in G1 phase by directly targeting CCNE1 in human hepatocellular carcinoma cells.
    Zhang X; Hu S; Zhang X; Wang L; Zhang X; Yan B; Zhao J; Yang A; Zhang R
    Biochem Biophys Res Commun; 2014 Jan; 443(3):1078-84. PubMed ID: 24370822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-125b-5p inhibits breast cancer cell proliferation, migration and invasion by targeting KIAA1522.
    Li Y; Wang Y; Fan H; Zhang Z; Li N
    Biochem Biophys Res Commun; 2018 Sep; 504(1):277-282. PubMed ID: 30177391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-143-5p Suppresses ER-Positive Breast Cancer Development by Targeting Oncogenic HMGA2.
    Mansoori B; Kiani S; Mezajin AA; Zandi P; Banaie H; Rostamzadeh D; Cho WC; Duijf PHG; Mansoori B; Baradaran B
    Clin Breast Cancer; 2023 Oct; 23(7):e480-e490.e3. PubMed ID: 37596147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p.
    Xiao B; Chen D; Zhou Q; Hang J; Zhang W; Kuang Z; Sun Z; Li L
    BMC Cancer; 2019 Sep; 19(1):891. PubMed ID: 31492116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiRNA-96-5p impacts the progression of breast cancer through targeting FOXO3.
    Yin Z; Wang W; Qu G; Wang L; Wang X; Pan Q
    Thorac Cancer; 2020 Apr; 11(4):956-963. PubMed ID: 32100957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.